Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

XERIS PHARMACEUTICALS INC (XERS) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $2.61 Metrics
OS: 66.5 M -421 % ROE
Market cap: $174 M -136 % ROIC
Net cash: $28.5 M $0.43 per share
EV: $145 M

 
TTM Valuation
EBITDA
EBIT ($75.6) M
EPS ($1.57)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16
Revenues20.21.60.00.00.1
            Revenue growth1138.8% -100.0%-69.8% 
Cost of goods sold9.31.6-2.40.00.0
Gross profit10.80.02.40.00.0
            Gross margin53.7%1.5% 75.0%84.9%
Selling, general and administrative73.763.121.18.0 
Research and development20.960.440.720.210.2
General and administrative    4.1
EBIT-83.5-122.4-59.3-26.6-13.2
            EBIT margin-414.5%-7521.8% -166431.3%-24964.2%
Pre-tax income-91.1-125.6-60.1-26.6-13.2
Income taxes0.10.50.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income-91.3-126.0-60.1-26.6-13.2
            Net margin-452.7%-7746.7% -165962.5%-24922.6%
 
Diluted EPS($2.14)($4.83)($4.99)($13.09)($7.17)
Shares outstanding (diluted)42.626.112.02.01.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy